To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
RoundTable to sell generic drug co for $565m
Swiss drug giant Novartis has agreed to buy Sabex from RoundTable Healthcare Partners, scoring a 150 percent gross return on its overall investment.
